DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology cover art

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

Listen for free

View show details

About this listen

 In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.

Hosted on Acast. See acast.com/privacy for more information.

What listeners say about DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.